Skip to main content

Aravind Asokan

Professor in Surgery
Surgery, Surgical Sciences

Research Interests


Virology
RNA Biology
Viral Engineering
RNA Engineering
Gene Therapy
Gene Editing
Gene Regulation
Regenerative Medicine

Selected Grants


Enhancing limb regeneration with gene therapy informed by comparative biology

ResearchCollaborator · Awarded by National Institutes of Health · 2024 - 2029

Determinants of AAV Tropism

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2008 - 2028

University Training Program in Biomolecular and Tissue Engineering

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1994 - 2027

Engineering cellular secretion for gene delivery

ResearchPrincipal Investigator · Awarded by National Institute of Biomedical Imaging and Bioengineering · 2023 - 2027

Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors

ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027

Enhancing limb regeneration with gene therapy informed by comparative biology

ResearchCollaborator · Awarded by National Institutes of Health · 2024 - 2029

Determinants of AAV Tropism

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2008 - 2028

University Training Program in Biomolecular and Tissue Engineering

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1994 - 2027

Engineering cellular secretion for gene delivery

ResearchPrincipal Investigator · Awarded by National Institute of Biomedical Imaging and Bioengineering · 2023 - 2027

Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors

ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027

Gene therapy for glycogen storage disease type III

ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2027

Dissecting AAV silencing in humanized mice

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2023 - 2027

Myovascular Mechanisms of Cardiac Growth and Regeneration

ResearchCollaborator · Awarded by National Institutes of Health · 2022 - 2026

Evaluation of adeno-associated viral (AAV) mediated gene replacement therapy as a therapeutic option for SLC25A4 deficiency

FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025

Evolving novel AAV vectors for gene therapy to cure HIV

ResearchPrincipal Investigator · Awarded by Oregon Health & Science University · 2022 - 2025

Evaluating Wnt-Modulators as a Therapy for Treatment of Arrhythmic Cardiomyopathy In Vivo

ResearchCollaborator · Awarded by Hartwell Foundation · 2022 - 2025

Reduction of Brain AVM Severity through Inhibition of Pathogenic Angiogenesis

ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2020 - 2025

Liver-directed AAV gene therapy for PHKG2-Glycogen Storage Disease IX (GSD IX y2)

FellowshipCo-Sponsor · Awarded by National Institutes of Health · 2021 - 2024

Targeted Therapy for Pompe Disease

ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2024

Evolving High Potency AAV Vectors for Neuromuscular Genome Editing

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2023

LUMICKS C-TRAP

EquipmentMajor User · Awarded by National Institutes of Health · 2022 - 2023

Epigenome Editing Technologies for Treating Diverse Disease

ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2023

AAV-Exosomes: Escaping Neutralizing Antibody and Enhancing Delivery

ResearchPrincipal Investigator · Awarded by Icahn School of Medicine at Mount Sinai · 2019 - 2023

Next Generation AAV Vectors for Kidney Gene Therapy

ResearchPrincipal Investigator · Awarded by BridgeBio Gene Therapy Research, Inc. · 2021 - 2023

AAV gene therapy for the treatment of Glycogen Storage Disease IX y2

ResearchInvestigator · Awarded by Kriya Therapeutics · 2022 - 2022

Editing the Kidney Epigenome

ResearchCo Investigator · Awarded by University of Washington · 2021 - 2022

CircRNAs and CNS Gene Transfer

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2022

RE-ENGINEERING AAV GENOME PACKAGING

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2022

Characterization of Recombinant Adeno-Associated Viral Vectors

ResearchPrincipal Investigator · Awarded by StrideBio LLC · 2019 - 2022

CRISPR/Cas9-Based Gene Editing for the Correction of Duchenne Muscular Dystrophy

ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2021

NONHUMAN PRIMATE TESTING CENTER FOR EVALUATION OF SOMATIC CELL GENOME EDITING TOOLS

ResearchPrincipal Investigator · Awarded by University of California - Davis · 2019 - 2020

External Relationships


  • Atsena Therapeutics
  • Coave Therapeutics
  • Ginkgo Bioworks
  • Kriya Therapeutics, Inc.
  • Mammoth Biosciences Inc
  • Atsena Therapeutics
  • Coave Therapeutics
  • Ginkgo Bioworks
  • Kriya Therapeutics, Inc.
  • Mammoth Biosciences Inc
  • Nvelop Therapeutics
  • Ring Therapeutics
  • Sphere Gene Therapeutics, Inc
  • TorqueBio Inc

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.